Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Andreas Josefsson

Researcher

Andreas Josefsson
Researcher
andreas.josefsson@urology.gu.se

Postal Address: Avd för Urologi vid Inst för Kliniska vetenskaper, 51345 Göteborg
Visiting Address: Bruna stråket 11b, vån 2, SU/Sahlgrenska , 41345 Göteborg


Department of Urology at Institute of Clinical Sciences (More Information)
Sahlgrenska Universitetssjukhuset
413 45 Göteborg
0313424145
Visiting Address: Bruna stråket 11b V 2 SU/Sahlgrenska , 413 45 Göteborg

Latest publications

TMPRSS2-ERG Expression Predicts Prostate Cancer Survival and Associates with Stromal Biomarkers
C. Hagglof, P. Hammarsten, K. Stromvall, L. Egevad, Andreas Josefsson et al.
Plos One, Journal article 2014
Journal article

High density of S100A9 positive inflammatory cells in prostate cancer stroma is associated with poor outcome.
Viktor Tidehag, Peter Hammarsten, Lars Egevad, Torvald Granfors, Pär Stattin et al.
European journal of cancer (Oxford, England : 1990), Journal article 2014
Journal article

Tumour epithelial expression levels of endocannabinoid markers modulate the value of endoglin-positive vascular density as a prognostic marker in prostate cancer.
Christopher J Fowler, Andreas Josefsson, Lina Thors, Sui Chu Chung, Peter Hammarsten et al.
Biochimica et biophysica acta, Journal article 2013
Journal article

Nuclear Stat5a/b predicts early recurrence and prostate cancer-specific death in patients treated by radical prostatectomy.
Tuomas Mirtti, Benjamin E Leiby, Junaid Abdulghani, Elina Aaltonen, Miia Pavela et al.
Human pathology, Journal article 2013
Journal article

Low endoglin vascular density and Ki67 index in Gleason score 6 tumours may identify prostate cancer patients suitable for surveillance.
Andreas Josefsson, Pernilla Wikström, Lars Egevad, Torvald Granfors, Lars Karlberg et al.
Scandinavian journal of urology and nephrology, Journal article 2012
Journal article

Phospho-Akt immunoreactivity in prostate cancer: relationship to disease severity and outcome, Ki67 and phosphorylated EGFR expression.
Peter Hammarsten, Mariateresa Cipriano, Andreas Josefsson, Pär Stattin, Lars Egevad et al.
PloS one, Journal article 2012
Journal article

Showing 1 - 10 of 16

2018

2017

2016

2014

TMPRSS2-ERG Expression Predicts Prostate Cancer Survival and Associates with Stromal Biomarkers
C. Hagglof, P. Hammarsten, K. Stromvall, L. Egevad, Andreas Josefsson et al.
Plos One, Journal article 2014
Journal article

High density of S100A9 positive inflammatory cells in prostate cancer stroma is associated with poor outcome.
Viktor Tidehag, Peter Hammarsten, Lars Egevad, Torvald Granfors, Pär Stattin et al.
European journal of cancer (Oxford, England : 1990), Journal article 2014
Journal article

2013

Tumour epithelial expression levels of endocannabinoid markers modulate the value of endoglin-positive vascular density as a prognostic marker in prostate cancer.
Christopher J Fowler, Andreas Josefsson, Lina Thors, Sui Chu Chung, Peter Hammarsten et al.
Biochimica et biophysica acta, Journal article 2013
Journal article

Nuclear Stat5a/b predicts early recurrence and prostate cancer-specific death in patients treated by radical prostatectomy.
Tuomas Mirtti, Benjamin E Leiby, Junaid Abdulghani, Elina Aaltonen, Miia Pavela et al.
Human pathology, Journal article 2013
Journal article

2012

Low endoglin vascular density and Ki67 index in Gleason score 6 tumours may identify prostate cancer patients suitable for surveillance.
Andreas Josefsson, Pernilla Wikström, Lars Egevad, Torvald Granfors, Lars Karlberg et al.
Scandinavian journal of urology and nephrology, Journal article 2012
Journal article

Phospho-Akt immunoreactivity in prostate cancer: relationship to disease severity and outcome, Ki67 and phosphorylated EGFR expression.
Peter Hammarsten, Mariateresa Cipriano, Andreas Josefsson, Pär Stattin, Lars Egevad et al.
PloS one, Journal article 2012
Journal article

Showing 1 - 10 of 16

Page Manager: Katarina Olinder Eriksson|Last update: 1/7/2014
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?